Co-Diagnostics (CODX) vs VolitionRX (VNRX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Co-Diagnostics is the larger company by market cap ($7.6 million vs $6.6 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | CODX | VNRX |
|---|---|---|
| Share price | $1.09 | $0.2194 |
| Market cap | $7.61M | $6.60M |
| 1-day change | -2.68% | -2.92% |
| EPS (TTM) | $-26.14 | $-3.80 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $46.50 | $12.80 |
| 52-week low | $0.906 | $0.217 |
| Distance from 52-week high | -97.66% | -98.29% |
| Analyst consensus | none | none |
| Avg. price target upside | +266.97% | +6107.84% |
| Average volume | 326.53K | 8.46M |
| Shares outstanding | 6.98M | 30.06M |
| Employees | 115 | 57 |
| Sector | Healthcare | Healthcare |
| Industry | Medical Devices | Medical Devices |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Co-Diagnostics
CODX stock →Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally.
Healthcare · Medical Devices · 115 employees
About VolitionRX
VNRX stock →VolitionRx Limited, a multi-national epigenetics company, develops blood tests to help detect and monitor a range of cancers, and diseases associated with NETosis in the United States, Europe, and Asia. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets, detects diseases associated with NETosis, such as sepsis; Nu.Q Discover, a solution to profiling nucleosomes.
Healthcare · Medical Devices · 57 employees
CODX vs VNRX FAQ
Which is bigger, Co-Diagnostics or VolitionRX?
Co-Diagnostics (CODX) is larger, with a market capitalization of $7.61M compared with $6.60M for VolitionRX (VNRX).
Are Co-Diagnostics and VolitionRX in the same industry?
Yes. Both are classified in the Medical Devices industry within the Healthcare sector.